Why you need to pay attention to the fifth emergency meeting on mpox in 2024—what it means for your health

DCM Editorial Summary: This story has been independently rewritten and summarised for DCM readers to highlight key developments relevant to the region. Original reporting by WHO, click this post to read the original article.

The World Health Organization (WHO) has officially announced that the 2024 mpox outbreak no longer qualifies as a Public Health Emergency of International Concern (PHEIC). This decision was made following the fifth meeting of the International Health Regulations (IHR) Emergency Committee, held on 4 September 2025. During the meeting, experts reviewed the current state of mpox transmission, severity, and international spread, concluding that the situation has significantly stabilized. Based on the Committee’s advice, the WHO Director-General, on 5 September 2025, confirmed that the outbreak no longer meets the criteria for a PHEIC.

You’ll be relieved to hear that the decision is backed by key improvements across several risk areas, including a notable decline in case numbers, better understanding of the disease’s transmission, and enhanced response capacity in affected countries, especially in Africa. For instance, cases in the Democratic Republic of the Congo, Sierra Leone, Burundi, and Uganda have steadily decreased. Meanwhile, transmission in other regions, including the UK, has largely been controlled and aligns with expected trends from the countries of origin.

Transmission is now better understood, with most spreading through close, intimate contact, particularly sexual contact among young adults. While some acute cases persist in children—especially in eastern provinces of the DRC—targeted public health interventions have proven effective. Advances in diagnostics, vaccines, and public engagement have also contributed to better outcomes. However, the WHO acknowledged that funding and competing health priorities continue to impact some areas’ ability to maintain momentum.

With this update, you’re encouraged to refocus mpox control efforts from emergency response to sustained, integrated health system programs. WHO recommends that countries maintain testing capabilities, improve community engagement to counter stigma and misinformation, and ensure equitable vaccine access and deployment. They also emphasized the need to include mpox care in broader health service platforms, particularly those related to HIV and STIs, to maximize efficiency and impact.

Finally, while the mpox crisis no longer qualifies as a global emergency, you’re reminded that continued vigilance is key. The WHO and its partners will transition toward long-term monitoring and support strategies, aiming to prevent future flare-ups without maintaining emergency status. Countries are urged to sustain current progress and ensure resources remain committed to mpox prevention, preparedness, and response.